nach oben

Erschienen in:

01.11.2016 | Case report

Dasabuvir/ombitasvir/paritaprevir/ritonavir

Polyserositis: case report

Einloggen, um Zugang zu erhalten

Author Information

An event is serious (FDA MedWatch definition) when the patient outcome is:

…

Pin ML, et al. Poliserositis in a patient with hepatitis C under treatment with new antivirals. Farmacia Hospitalaria 40: 447-448, No. 5, Sep 2016. Available from: URL: http://doi.org/10.7399/fh.2016.40.5.10475 [Spanish; summarised from a translation] - Spain

Titel: Dasabuvir/ombitasvir/paritaprevir/ritonavir
Polyserositis: case report
Publikationsdatum: 01.11.2016
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2016
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-016-22644-z